Ardent Health (ARDT) Cash & Equivalents (2023 - 2026)

Ardent Health's Cash & Equivalents history runs 4 years deep, the most recent figure standing at $609.7 million for Q1 2026.

• In Q1 2026, Cash & Equivalents rose 23.16% year-over-year to $609.7 million; the TTM figure through Mar 2026 stood at $609.7 million (up 23.16% YoY), while the FY2025 annual figure was $709.6 million, up 27.45% from the prior year.
• Cash & Equivalents was $609.7 million for Q1 2026 at Ardent Health, down from $709.6 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $709.6 million in Q4 2025 to a low of $334.5 million in Q2 2024.
• Historically, Cash & Equivalents has averaged $539.6 million across 4 years, with a median of $556.8 million in 2024.
• Biggest YoY gain for Cash & Equivalents was 61.6% in 2025; the steepest drop was 8.22% in 2025.
• A 4-year view of Cash & Equivalents shows it stood at $437.6 million in 2023, then gained by 27.24% to $556.8 million in 2024, then grew by 27.45% to $709.6 million in 2025, then retreated by 14.08% to $609.7 million in 2026.
• The last three Cash & Equivalents figures came in at $609.7 million (Q1 2026), $709.6 million (Q4 2025), and $609.4 million (Q3 2025), per Business Quant data.